LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 146.96

Change

0.00 (0.00)%

Market Cap

USD 0.28B

Volume

1.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-10 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-1.10 (-3.36%)

USD 11.50B
QLD ProShares Ultra QQQ 0.95 %

-0.39 (-0.35%)

USD 7.95B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+11.15 (+2.17%)

USD 5.90B
SSO ProShares Ultra S&P500 0.90 %

-0.62 (-0.64%)

USD 5.68B
UPRO ProShares UltraPro S&P500 0.92 %

-0.93 (-0.97%)

USD 4.34B
TECL Direxion Daily Technology Bull.. 1.17 %

+0.20 (+0.21%)

USD 3.15B
YINN Direxion Daily FTSE China Bull.. 1.02 %

-3.54 (-11.10%)

USD 2.02B
USD ProShares Ultra Semiconductors 0.95 %

+0.75 (+1.06%)

USD 1.40B
DPST Direxion Daily Regional Banks .. 1.02 %

-2.58 (-1.69%)

USD 0.88B
UDOW ProShares UltraPro Dow30 0.95 %

-2.69 (-2.49%)

USD 0.79B

ETFs Containing LABU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9,539.09% 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 9,539.09% 97% N/A 99% N/A
Trailing 12 Months  
Capital Gain 21,354.01% 99% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 21,354.01% 99% N/A 99% N/A
Trailing 5 Years  
Capital Gain 1,361.92% 94% A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,361.92% 94% A 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 450.36% 97% N/A 99% N/A
Dividend Return 450.46% 97% N/A 99% N/A
Total Return 0.10% 8% B- 4% F
Risk Return Profile  
Volatility (Standard Deviation) 2,684.85% 4% F 1% F
Risk Adjusted Return 16.78% 31% F 34% F
Market Capitalization 0.28B 84% B 57% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.